Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Obsessive Compulsive Disorder

Where the ritual ends and the compulsion begins

    • Congress Reports
    • Psychiatry and psychotherapy
    • RX
  • 3 minute read

Already in childhood, the first symptoms may appear – obsessive-compulsive disorder. They are among the most common mental disorders. Often concealed, treatment rates are low. There are good therapeutic options for this.

Obsessive-compulsive disorder is a neuropsychiatric disorder and usually manifests between the ages of 18 and 25, although initial symptoms may appear in childhood. The disease often accompanies those affected throughout their lives and carries a high rate of psychiatric comorbidities. It also has a strong impact on everyday life, professional performance and social relationships, as Prof. Ulrich Voderholzer, MD, Prien am Chiemsee (D), made clear. Intensive research on phenomenology, psychobiology, pharmacotherapy, and psychotherapy has contributed to a much better understanding of the entity. For example, similar to other neuropsychiatric disorders, genetic research revealed more multiple and complex genetic factors, with heritability accounting for approximately 40%.

Progress has been made with regard to obsessive-compulsive spectrum disorders, which have been upgraded as independent disorders by the changes in the DSM-5 and also ICD-11 classification systems, the expert said. With the classification as obsessive-compulsive spectrum disorders, such as hypochondriacal disorder, body dysmorphic disorder, olfactory reference disorder, pathological hoarding, and other disorders, the focus is directed more strongly to the typical symptoms that also occur in obsessive-compulsive disorders, such as repetitive behaviors, rituals, and avoidance behaviors, which in turn represent starting points for more effective, primarily psychotherapeutic therapy concepts (Fig. 1).

 

 

Ritual or compulsion?

To understand obsessive-compulsive symptoms, scientists have observed behavioral routines in animals. Motor stereotypies, repetitive and ritualized behavior is ubiquitous in the animal kingdom. Ritualized behavior also occurs in all human cultures and is conserved over long periods of development. For the transition between routines and ritualized behavior (ritualized here means redundant, no longer required or functional behavior), specifically unstable, hard-to-predict environmental conditions play a role. Rituals in humans then have a balancing or equilibrium function, especially under unstable, hardly predictable environmental conditions, in order to reduce anxiety and to create an experience of control and predictability for one’s own person.

A Danish cohort study of 1.3 million children assessed the annual incidence for psychiatric diagnoses. For the first time, it was thus also possible to record the course of incidence rates and also the cumulative incidence for obsessive-compulsive disorder up to the age of 18 . There was an increasing incidence for obsessive-compulsive disorder as early as 6 years of age. Up to 12 years of age, girls and boys were affected at about the same rate; from puberty onward, the incidence rate was higher in girls compared with boys. In girls, the cumulative incidence by 18 years of age reached just under 1%, and in boys, 0.6%. “This epidemiological study shows that obsessive-compulsive disorder manifests as early as 6 years of age. Approximately 50% of childhood obsessive-compulsive disorders occur before the age of 13,” the expert cautioned.

State of the Art Therapy

Therapies with the highest evidence for obsessive-compulsive disorder include cognitive behavioral therapy (CBT) with exposure and response management and selective serotonin reuptake inhibitors (SSRIs and clomipramine). In addition, there is evidence for atypical antipsychotics and other augmentation strategies for treatment resistance (Table 1). Several new therapeutic studies exist on neurostimulation procedures. However, the relevance to the care of people with OCD of these procedures remains extremely low.

 

 

However, the most effective therapy for compulsions is too rarely used worldwide. Voderholzer summarizes the current problem of KVT application as follows: Rejection or discontinuation of treatment with CT and exposure affects about one third of patients and is thus comparable or even lower than in other psychotherapies. The review of the work between the sessions is particularly important, as the success of the therapy depends significantly on this. However, the rejection of CT with exposure is not the central problem of care, but rather the far too infrequent use overall, despite decades of very good evidence for the high efficacy of CT with exposure. Improving the dissemination of CT and reducing barriers to its use are the most important challenges to improving care.

Source: “Obsessive-compulsive disorders and obsessive-compulsive spectrum disorders,” lecture and abstract. Psychiatry UpDate 2020

 

Literature:

  1. Stein, et al: Nature Reviews Disease Primer 2019; 5: 52.
  2. Hohagen F, Wahl-Kordon A, Lotz-Rambaldi W, Muche-Borowski C (eds.): S3-Leitlinie Zwangsstörungen. 2014. Berlin: Springer-Verlag.

 

InFo NEUROLOGY & PSYCHIATRY 2020; 18(2): 30-31 (published 3/24/20, ahead of print).

Autoren
  • Leoni Burggraf
Related Topics
  • Coercion
  • Compulsive spectrum disorder
  • Obsessive Compulsive Disorder
Previous Article
  • Cardiovascular diseases

When the skin beats on the heart

  • Cardiology
  • Dermatology and venereology
  • Education
  • Rheumatology
  • RX
View Post
Next Article
  • SARS-CoV-2

Protective measures after the end of the lockdown

  • Congress Reports
  • General Internal Medicine
  • Infectiology
  • Interviews
  • News
  • Prevention and health care
  • RX
View Post
You May Also Like
View Post
  • 8 min
  • Proteins in wound healing

Do special amino acids lead to success?

    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • HER2+ early breast cancer

DESTINY-Breast11 – neoadjuvant T-DXd without anthracyclines

    • Education
    • Gynecology
    • Oncology
    • RX
    • Studies
View Post
  • 3 min
  • Lavender aromatherapy

Take away the fear of the dentist

    • Dentistry
    • Education
    • Pharmaceutical medicine
    • Phytotherapy
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Digital dermatology: innovative project examples

AI and eHealth tools in HS care

    • Dermatology and venereology
    • General Internal Medicine
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 5 min
  • Mantle cell lymphoma

Recurrence after BTK inhibition – prognostic factors and treatment options

    • Education
    • Hematology
    • Oncology
    • RX
View Post
  • 3 min
  • Dementia risk with type 2 diabetes

SGLT2 inhibitors with advantages vs. DPP4 inhibitors

    • Education
    • Endocrinology and Diabetology
    • Geriatrics
    • Neurology
    • Pharmacology and toxicology
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 15 min
  • T helper 1 cells

Differentiation and activation of Th1 cells – a multi-omics approach

    • RX
    • CME continuing education
    • General Internal Medicine
    • Genetics
    • Prevention and health care
View Post
  • 4 min
  • Cannabis for schizophrenia

CBD pre-treatment could exacerbate side effects

    • Education
    • Pharmacology and toxicology
    • Phytotherapy
    • Psychiatry and psychotherapy
    • RX
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Communication as the key to therapy adherence
  • 2
    Solutions to the malnutrition dilemma
  • 3
    Solutions to the malnutrition dilemma
  • 4
    Focus on preventive care options
  • 5
    Fertility preservation from gonads to genomes to genoids

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.